Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

CELG

Celgene (CELG)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CELG
DataOraFonteTitoloSimboloCompagnia
16/12/201913:30GlobeNewswire Inc.NexImmune Appoints Sol Barer as Chairman of the Board of DirectorsNASDAQ:CELGCelgene Corporation
21/11/201912:21PR Newswire (US)Amgen Completes Acquisition Of Otezla® (apremilast)NASDAQ:CELGCelgene Corporation
20/11/201922:18Business WireCelgene Announces Plans to Transfer Listing of Celgene’s Contingent Value Rights Following Closing of Acquisition by Bristo...NASDAQ:CELGCelgene Corporation
20/11/201920:09Business WireCELGENE ERHÄLT DIE ZULASSUNGSEMPFEHLUNG DES CHMP FÜR LENALIDOMID (REVLIMID®) IN KOMBINATION MIT RITUXIMAB ZUR BEHANDLUNG V...NASDAQ:CELGCelgene Corporation
19/11/201917:16PR Newswire (US)Thermo Fisher Scientific Set to Join S&P 100; ServiceNow to Join S&P 500NASDAQ:CELGCelgene Corporation
18/11/201923:10GlobeNewswire Inc.Exelon Corporation to Join the NASDAQ-100 Index Beginning November 21, 2019NASDAQ:CELGCelgene Corporation
15/11/201923:39Dow Jones NewsFTC Requires Bristol-Meyers Squibb, Celgene to Divest Otezla as Condition of AcquisitionNASDAQ:CELGCelgene Corporation
15/11/201914:22Dow Jones NewsCelgene Gets CHMP Positive Opinion for Revlimid/Rituximab Combo in Follicular LymphomaNASDAQ:CELGCelgene Corporation
15/11/201913:30Business WireCelgene Receives CHMP Positive Opinion for REVLIMID® (lenalidomide) in Combination With Rituximab for the Treatment of Adult...NASDAQ:CELGCelgene Corporation
13/11/201904:28PR Newswire (Canada)Skyhawk Therapeutics annonce une deuxième entente de collaboration multicible avec Celgene pour découvrir et mettre au poin...NASDAQ:CELGCelgene Corporation
12/11/201915:00PR Newswire (US)Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small...NASDAQ:CELGCelgene Corporation
08/11/201919:30Dow Jones NewsAcceleron Pharma Shares Gain Ground After FDA Approves ReblozylNASDAQ:CELGCelgene Corporation
08/11/201919:20Dow Jones NewsFDA Approves Celgene's and Acceleron's Reblozyl to Treat Rare Blood DisorderNASDAQ:CELGCelgene Corporation
08/11/201918:33Business WireFDA Approves REBLOZYL® (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular R...NASDAQ:CELGCelgene Corporation
06/11/201922:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
06/11/201915:06Business WireCelgene to Present New & Updated Data on Key Hematology Pipeline Therapies at American Society of Hematology (ASH) 2019 Annua...NASDAQ:CELGCelgene Corporation
31/10/201921:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CELGCelgene Corporation
31/10/201912:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELGCelgene Corporation
31/10/201912:30Business WireCelgene Reports Third Quarter 2019 Operating and Financial ResultsNASDAQ:CELGCelgene Corporation
16/10/201912:00Business WireCelgene & the Multiple Sclerosis Association of America Take the MS MindShift Initiative & “Brain Bulb” Hot Air Balloon t...NASDAQ:CELGCelgene Corporation
20/09/201913:30Business WireCelgene Corporation Names Second Round of Celgene Cancer Care Links™ Program Grant RecipientsNASDAQ:CELGCelgene Corporation
12/09/201922:30Business WireCelgene Announces Phase 3 QUAZAR® AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myel...NASDAQ:CELGCelgene Corporation
11/09/201918:24Dow Jones NewsSwiss Biotech Anokion Raises $40 Million in Series B RoundNASDAQ:CELGCelgene Corporation
09/09/201913:30Business WireData from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress...NASDAQ:CELGCelgene Corporation
27/08/201909:02Dow Jones NewsCelgene, Bristol Clear Way For Merger -- WSJNASDAQ:CELGCelgene Corporation
26/08/201917:14Dow Jones NewsAmgen to Buy Celgene's Otezla for $13.4 Billion--UpdateNASDAQ:CELGCelgene Corporation
26/08/201913:49Dow Jones NewsAmgen to Buy Celgene's Otezla for $13.4 Billion -- UpdateNASDAQ:CELGCelgene Corporation
26/08/201913:14Dow Jones NewsAmgen to Buy Celgene's Otezla for $13.4 BillionNASDAQ:CELGCelgene Corporation
26/08/201912:30PR Newswire (US)Amgen To Acquire Otezla® For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefi...NASDAQ:CELGCelgene Corporation
21/08/201914:45InvestorWireRecord Revenues, Milestone Achievements Indicate Strength, Potential of Biotech SectorNASDAQ:CELGCelgene Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CELG

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network